Systematic review of randomized trials for the treatment of oral leukoplakia

Journal of Dental Education

Volumn 66, Issue 8, 2002, Pages 896-902

  Lodi, Giovanni ^a   Sardella, Andrea ^a   Bez, Cristina ^a   Demarosi, Federica ^a   Carrassi, Antonio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Meta analysis; Oral leukoplakia; Precancerous condition oral cancer; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CAROTENE; BLEOMYCIN; RETINOID;

CELL TRANSFORMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LEUKOPLAKIA; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TEA; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BETA CAROTENE; BLEOMYCIN; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LEUKOPLAKIA, ORAL; META-ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RETINOIDS; TEA;

EID: 0036689094     PISSN: 00220337     EISSN: 19307837     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996;25:49-54.
2. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-39.
3. Axell T, Holmstrup P, Kramer I, Pindborg JJ, Shear M. International seminar on oral leucoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol 1984;12:145-54.
4. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23, 616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 1986;61:373-81.
5. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20, 333 adult Swedish people. Community Dent Oral Epidemiol 1987;15:46-51.
6. Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol 1991;19:160-3.
7. Reichart PA. Oral mucosal lesions in a representative cross-sectional study of aging Germans. Community Dent Oral Epidemiol 2000;28:390-8.
8. Silverman S Jr., Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 1984;53:563-8.
9. Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res 1987;95:449-55.
10. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a followup study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998;34:270-5.
11. Scully C, Porter S. ABC of oral health. Oral cancer. BMJ 2000;321:97-100.
12. Warnakulasuriya S. Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 2000;190:407-9.
13. Sudbo J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol 2001;37:558-65.
14. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8.
15. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 2002.
16. Mulrow CD, Oxman AD. The Cochrane Collaboration Handbook, Version 4, 1997.
17. Sackett DL, Straus S, Richardson WS, Rosenberg W, Haines RB. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Edinburgh, U.K.: Churchill Livingstone, 2000.
18. Garewall HS, Katz RV, Meyskens F, et al. Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial. Arch Otolaryngol Head Neck Surg 1999;125:1305-10.
19. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis [see comments]. N Engl J Med 1993;328:15-20.
20. Boisnic S, Branchet MC, Pascal F, Ben Slama L, Rostin M, Szpirglas H. Tretinoine topique dans le traitement des lichens plans et des leucoplasies de la muqueuse buccale. Evaluation clinique. Ann Dermatol Venereol 1994;121:459-63.
21. Krishnaswamy K, Prasad MP, Krishna TP, Annapurna VV, Reddy GA. A case study of nutrient intervention of oral precancerous lesions in India. Eur J Cancer B Oral Oncol 1995;31B:41-8.
22. Zaridze D, Evstifeeva T, Boyle P. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann Epidemiol 1993;3:225-34.
23. Beenken SW. Fenretinide in treating patients with leucoplakia of the mouth. www.controlled-trials.com.
24. De Palo G, Veronesi U, Marubini E, et al. Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia. J Cell Biochem Suppl 1995;22:11-7.
25. Magnuson WG. Randomized, double blind, placebo-controlled, phase IIB trial of ketorolac mouth rinse: evaluating the effect of cyclooxigenase inhibition on oropharingeal leucoplakia: collaborative study of the NCI, NIDCD and the NIDR. www.controlled-trials.com.
26. Epstein JB, Wong FL, Millner A, Le ND. Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial. Head Neck 1994;16:539-44.
27. Piattelli A, Fioroni M, Santinelli A, Rubini C. bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study. Oral Oncol 1999;35:314-20.
28. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-5.
29. Sankaranarayanan R, Mathew B, Varghese C, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol 1997;33:231-6.
30. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988;40:93-101.
31. Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc Soc Exp Biol Med 1999;220:218-24.
32. Gupta PC. Leukoplakia and incidence of oral cancer. J Oral Pathol Med 1989;18:17.
33. Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000;82:1871-4.
34. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:321-9.
35. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:188-91.
36. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995;24:198-200.
37. Marley JJ, Linden GJ, Cowan CG, et al. A comparison of the management of potentially malignant oral mucosal lesions by oral medicine practitioners and oral & maxillofacial surgeons in the UK. J Oral Pathol Med 1998;27:489-95.
38. Saito T, Sugiura C, Hirai A, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001;30:49-53.